Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PHYTORELIEF-CC is a natural herbal supplement and phytomedicine developed by Alchem International under the AlchemLife brand. Formulated as sugar-free lozenges, it is indicated for the prevention and symptomatic relief of upper respiratory tract infections, including cough, the common cold, influenza, and sore throat. The product utilizes a patented combination of high-potency phyto-actives derived from ginger (*Zingiber officinale*), turmeric (*Curcuma longa*), and pomegranate (*Punica granatum*). Its mechanism of action involves the creation of a physical protective barrier on the respiratory mucosa and the activation of salivary lysozymes, which serve as a primary innate immune defense against viral and bacterial pathogens. Clinical data suggests the formulation can significantly enhance lysozyme levels, providing anti-viral, anti-bacterial, and anti-inflammatory effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PHYTORELIEF-CC.